PATENT CLAIM ANALYSIS

Application Number: 16357340
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-09
Patent Classification: ["530", "311000"]

Abstract:
Disclosed are Somatostatin receptor ligands comprising a peptide moiety, pharmaceutical compositions and uses thereof. Disclosed are also synthetic Somatostatin receptor ligands comprising a cyclic peptide moiety and an active agent moiety covalently bonded to the cyclic peptide moiety through a nitrogen atom of a side chain functional group of an internal residue of the cyclic peptide moiety, pharmaceutical compositions and uses thereof. Disclosed are also synthetic Somatostatin receptor ligands comprising a cyclic peptide moiety and a nanoparticle active agent moiety covalently bonded to the cyclic peptide moiety, pharmaceutical compositions and uses thereof.

Claim (Index 6):
The somatostatin receptor ligand according to  claim 1  in the form of an amide wherein the GlyS2 is amidated at the C-terminus.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 99.0
- Lexical Diversity: 2.64865
- Patent Class: 530.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15509842', '10950378', '11041676', '15263028', '10554240']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7626224981891483
- 35 USC 102 Novelty (BERT): 0.6473017033757327
- Combined Prediction Score: 0.7510904187078067
- Mean Citation Score: 466.76161600000006
- Max Citation Score: 754.19617
- Similarity Product: 567.3251552868368

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test